FDA gives HDE (humanitarian device exemption) approval for gastric stimulation system
This article was originally published in Clinica
The US FDA has approved Medtronic's implantable electrical stimulation device for treating patients with a rare but severe and often life-threatening form of gastroparesis, a gastrointestinal disorder marked by chronic vomiting and nausea.
You may also be interested in...
As part of a periodic review, FDA is bringing together experts to review several products that are conditionally available for pediatric use under the agency's Humanitarian Device Exemption program.
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.